2204 RESULTS
CONFERENCE 2007-02-18 00:00:00-2007-02-23 00:00:00 Ventura Beach Marriott, Ventura, CA, U.S.A. 18 – 23 February 2007 Quantitative genetics aims to link phenotypic variation to its underlying genetic basis in order to better understand and predict genetic composition and long term change within n
CONFERENCE 2007-02-05 00:00:00-2007-02-06 00:00:00 Westin Hotel, New York, NY, U.S.A. 05 – 06 February 2007 The conference presented by Alzheimer’s Drug Discovery Foundation & Institute for the Study of Aging and will provide academic and biotechnology scientists with an overview of the drug
CONFERENCE 2007-02-04 00:00:00-2007-02-09 00:00:00 Big Sky Resort, Big Sky, MT, U.S.A. 04 – 09 February 2007 Our understanding of how ubiquitin regulates cellular functions has greatly expanded in the past several years, spurred by discoveries of protein families involved in ubiquitin conjugatio
CONFERENCE 2007-02-01 00:00:00-2007-02-06 00:00:00 Fairmont Chateau Lake Louise, Lake Louise, Alberta, Canada 01 – 06 February 2007 Sponsored by Abbott Laboratories, Inc. Therapeutic antibodies have become important components of standard care in some areas of clinical practice, but lag behind i
CONFERENCE 2007-01-28 00:00:00-2007-02-02 00:00:00 Four Points Sheraton: Harbortown, Ventura, CA, U.S.A. 28 January – 02 February 2007 Metals play many important roles in biological systems, from essential functional or structural cofactors in proteins, to environmental toxins. The Metals in Bio
CONFERENCE 2007-01-28 00:00:00-2007-02-02 00:00:00 Keystone Resort, Keystone, CO, U.S.A. 28 January – 02 February 2007 Sponsored by Alnylam Pharmaceuticals, Inc. RNA Interference (RNAi) remains a promising new approach for gene silencing both in the context of post-genomic research on target val
CONFERENCE 2007-01-28 00:00:00-2007-02-02 00:00:00 Keystone Resort, Keystone, CO, U.S.A. 28 January – 02 February 2007 Sponsored by Novartis Institutes for BioMedical Research. MicroRNAs (miRNAs) and endogenous small interfering RNAs (siRNAs) act as guide RNAs to direct gene-silencing pathways i
CONFERENCE 2007-01-16 00:00:00-2007-01-21 00:00:00 Sagebrush Inn and Conference Center, Taos, NM, U.S.A. 16 – 21 January 2007 Evidence is accumulating that in chronic neurodegenerative diseases such as Alzheimer disease (AD), Parkinson disease (PD), Huntington disease (HD), and amyotrophic later
CONFERENCE 2007-01-14 00:00:00-2007-01-19 00:00:00 Ventura Beach Marriott, Ventura, CA, U.S.A. 14 – 19 January 2007 The biannual GRC on RNA Editing is the only regularly scheduled meeting on this subject. It will convene a relatively small group of established leaders and junior scientists in a
CONFERENCE 2007-01-14 00:00:00-2007-01-19 00:00:00 Keystone Resort, Keystone, CO, U.S.A. 14 – 19 January 2007 Diabetes is a growing threat to public health worldwide. Type 2 diabetes results from insulin resistance and impaired beta cell function. Studies of insulin signaling and its interaction
CONFERENCE 2006-12-13 00:00:00-2006-12-13 00:00:00 New York Academy of Sciences, New York, NY, U.S.A. 13 December 2006 The Neuroimmunology Discussion Group focuses on the interface between the immune system and the nervous system both in the brain and in the periphery, in normal and pathological condition
CONFERENCE 2006-12-08 00:00:00-2006-12-09 00:00:00 Technische Universität München, Munich, Germany 08 – 09 December 2006 The symposium is organized by the departments of Nuclear Medicine and Psychiatry of the Technical University of Munich. Leading international scientists are invited as speaker
CONFERENCE 2006-12-05 00:00:00-2006-12-05 00:00:00 New York Academy of Sciences, New York, NY, U.S.A. 05 December 2006 Argonaute proteins and associated small RNAs have critical role in development by regulating messenger RNA stability, protein synthesis, chromatin organization and genome structure. In an
CONFERENCE 2006-12-05 00:00:00-2006-12-05 00:00:00 New York Academy of Sciences, New York, NY, U.S.A. 05 December 2006 This meeting is being held jointly with the American Chemical Society's New York Section. This is an all day event. Alzheimer's disease (AD) is characterized by the neuropatholo
CONFERENCE 2006-12-04 00:00:00-2006-12-06 00:00:00 Pennsylvania Convention Center, Philadelphia, PA, U.S.A. 04 – 06 December 2006 Medicinal Chemistry at M3D will examine drug design and lead optimization, biological processes and process development, metabolic and toxicological processes, genomi
